Compugen(CGEN) Stock Price Today | Quotes & News

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Compugen to Participate in Multiple Virtual Investor Conferences in April 2025
PR Newswire07:00 ET
Calculating The Intrinsic Value Of Compugen Ltd. (NASDAQ:CGEN)
Yahoo FinanceMar 6 06:19 ET
Truist Financial Maintains Compugen(CGEN.US) With Buy Rating
Moomoo NewsMar 5 07:33 ET · Ratings
Compugen Ltd. (NASDAQ:CGEN) Looks Inexpensive After Falling 27% But Perhaps Not Attractive Enough
Simply Wall StMar 5 06:16 ET
Compugen's 2024 Results Highlight Clinical Progress and Financial Stability
TipRanksMar 4 22:56 ET
Compugen's Earnings Call: A Cautiously Optimistic Outlook
TipRanksMar 4 19:04 ET

Comments

Teddy123

Feb 26 20:13

Compugen Enhances its AI/ML Predictive Computational Discovery Platform, Unigen™ with Ultima Genomics' Single Cell Genomics Sequencing Technology

$Compugen (CGEN.US)$
How Compugen's AI Platform Partnership Could Revolutionize Cancer Immunotherapy Discovery

Jaguar8

Feb 26 20:02

NEWS

$Compugen (CGEN.US)$
Compugen Enhances its AI/ML Predictive Computational Discovery Platform, Unigen™ with Ultima Genomics' Single Cell Genomics Sequencing Technology
NEWS PROVIDED BY
Compugen Ltd.
Feb 26, 2025, 07:00 ET
Gene structure information identified by combining Compugen's AI/ML predictive computational discovery platform, Unigen™ with Ultima's UG 100™ sequencing platform to better understand tumor biology and immune regulation
Leveraging Compugen's computational analytical tools un...

Teddy123

Jan 31 13:37

TROPION-Lung12 Phase 3 Trial Initiated Evaluating DATROWAY® as Part of Adjuvant Regimen for Patients with Early-Stage Non-Small Cell Lung Cancer at High Risk of Relapse

$AstraZeneca (AZN.US)$ $Compugen (CGEN.US)$
Major Breakthrough: AstraZeneca's New Weapon Against Early-Stage Lung Cancer Enters Final Testing

1

Jaguar8

Jan 8 23:36

NEWS TODAY

$Compugen (CGEN.US)$
Compugen Announces First Patient Dosed in Phase 1 Clinical Trial to Evaluate COM503 as Monotherapy and in Combination with Zimberelimab in Advanced Solid Tumors
Wednesday, 8th January at 7:00 am
• New approach to harness cytokine biology to treat cancer patients advances to the clinic
• First patient dosed with potential first-in-class anti-IL-18 binding protein antibody, COM503, licensed to Gilead Sciences, Inc.
• Phase 1 dose escalation and dose expansion trial...

4

Jaguar8

Dec 16, 2024 10:58

🔶December 2024 Upcoming Catalysts. Save it. In alphabetical order

$ABVC BioPharma (ABVC.US)$ - Progress continues in our ADHD program with Phase IIb trials at multiple prominent sites. We aim to have an interim report by Q4 2024. ABV-1601 for MDD in cancer patients has completed Phase I study preparation, including the Site Initiation Visit (SIV). The study is set to initiate by the end of 2024.
$Ascent Solar Technologies (ASTI.US)$- Following delivery and the successful completion of the on-orbi...

28

9

7

CGEN Compugen

Trade Overview

Capital Trend

News

Comments